As mutations in high-susceptibility genes greatly increase risk of melanoma development, individuals carrying CDKN2A, CDK4, BAP1, POT1, or MITF mutations should be educated on the importance of melanoma prevention and early detection and should undergo regular medical skin examination [15]. The gene discussed is CDKN2A; the disease is melanoma.